title: Presence in mouse Sertoli cell-conditioned medium of a factor that expresses AVP-like inhibition of steroidogenesis by mouse Leydig cells in long-term culture.
abstract: The influence of spent medium from immature mouse Sertoli cells (SCM) on testosterone production by purified Leydig cells was investigated and compared to that of AVP, a potent local modulator of Leydig cell steroidogenesis. SCM inhibited in a dose-dependent manner the hCG-stimulated testosterone production, but was ineffective in basal conditions. As is known for AVP, (i) a lag period of 72 h was prerequisite for SCM to inhibit Leydig cell function; (ii) the main effect of SCM was located at a step beyond the receptor-adenylate cyclase system, since the hCG- and 8-bromo-cAMP-stimulated testosterone productions were similarly affected. The possibility that the effect of SCM may be related to AVP-like molecule(s) is also supported by the observations that at maximal concentrations the inhibitory effects of AVP and SCM were not additive and that the inhibition of testosterone production was largely (65%) reversed by the presence of [(beta-mercapto-beta, beta-cyclopentamethylenepropionyl, O-Me-Tyr2,Arg8)-vasopressin], a selective vasopressor antagonist. These data indicate that Sertoli cells produce in vitro potent inhibitory factors of Leydig cell steroidogenesis. They provide additional evidence that one of these bioactive factors has an effect on Leydig cell function similar to that of AVP.
authors.affiliation: Laboratoire d'Endocrinologie et de Biologie de la Reproduction, UFR Santé Médecine Biologie Humaine, Bobigny, France.
authors.forename: C
authors.initials: C
authors.lastname: Fillion
authors.forename: A
authors.initials: A
authors.lastname: Tahri-Joutei
authors.forename: J N
authors.initials: JN
authors.lastname: Hugues
authors.forename: A M
authors.initials: AM
authors.lastname: Allevard
authors.forename: N
authors.initials: N
authors.lastname: Taïb
authors.forename: G
authors.initials: G
authors.lastname: Pointis
mesh_terms: D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin / Q000494:pharmacology*; D001685:Biological Factors / Q000302:isolation & purification* / Q000378:metabolism / Q000494:pharmacology; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D017077:Culture Media, Conditioned / Q000737:chemistry*; D003864:Depression, Chemical; D007985:Leydig Cells / Q000187:drug effects*; D008297:Male; D051379:Mice; D012708:Sertoli Cells / Q000378:metabolism*; D013739:Testosterone / Q000096:biosynthesis*
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D001685:Biological Factors; D006063:Chorionic Gonadotropin; D017077:Culture Media, Conditioned; D001127:Arginine Vasopressin; D015124:8-Bromo Cyclic Adenosine Monophosphate; D013739:Testosterone